From: Bloomberg
By Sam Chambers
-
Co. to test Neocore device with consumers after FDA approval
- BAT plans Alto, nicotine-salt product, to compete with Juul
***
BAT’s first-half profit of 4.82 billion pounds ($6.4 billion) was slightly ahead of analysts’ estimates. The London-based company said it received approval from the U.S. Food and Drug Administration to begin selling its Neocore heated-tobacco device, which was formerly known as Eclipse.
First Mover
BAT inherited Neocore from Reynolds when it acquired the business last year. Eclipse had already received FDA approval, which enabled BAT to fast-track its application this time around. Neocore is a carbon-tipped product that is lit with a match yet doesn’t burn the tobacco. The company will carry out consumer tests of the product during the next 12 months, according to Jerry Abelman, BAT’s head of external affairs.